Tonix Pharmaceuticals Holding TNXP paid Strategic Marketing Innovations $10K for lobbying in Q4 2025 · Defense, Health Issues

Trade details

Type: Lobbying report
Amount: $10,000
Quarter: Q4 2025
Stock: Tonix Pharmaceuticals Holding TNXP
Client: Tonix Pharmaceuticals
Reported: 26/01/21

$510K on lobbying in 2025

What else happened in Tonix Pharmaceuticals Holding around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

Tonix Pharmaceuticals's other lobbying reports

Tonix Pharmaceuticals
LobbyingTonix Pharmaceuticals Holding
Lobbying
Tonix Pharmaceuticals Holding
TNXP
$20K
$20K
Reported 08/07
for Q3
Tonix Pharmaceuticals
LobbyingTonix Pharmaceuticals Holding
Lobbying
Tonix Pharmaceuticals Holding
TNXP
$30K
$30K
Reported 07/20
for Q2
Tonix Pharmaceuticals
LobbyingTonix Pharmaceuticals Holding
Lobbying
Tonix Pharmaceuticals Holding
TNXP
$40K
$40K
Reported 07/19
for Q2
Tonix Pharmaceuticals
LobbyingTonix Pharmaceuticals Holding
Lobbying
Tonix Pharmaceuticals Holding
TNXP
$20K
$20K
Reported 07/18
for Q2
Tonix Pharmaceuticals
LobbyingTonix Pharmaceuticals Holding
Lobbying
Tonix Pharmaceuticals Holding
TNXP
$40K
$40K
Reported 07/17
for Q2